Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery

Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery

Aims To determine if treatment with sitagliptin, a dipeptidyl peptidase-4 inhibitor, can prevent stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.Methods We conducted a pilot, double-blinded, placebo-controlled randomized trial in adults (18–80...

Full description

Saved in:
Bibliographic Details
Main Authors: Saumeth Cardona, Priyathama Vellanki, Maya Fayfman, Rodolfo J Galindo, Francisco J Pasquel, Katerina Tsegka, Limin Peng, Sol Jacobs, Michael Halkos, Robert A Guyton, Vinod H Thourani, Guillermo Umpierrez
Format: Article
Language:English
Published: BMJ Publishing Group 2019-05-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/7/1/e000703.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://drc.bmj.com/content/7/1/e000703.full

Similar Items